Herbalife upgraded to Buy at Argus on resumption of growth in 2025

As previously reported, Argus upgraded Herbalife (HLF) to Buy from Hold with a price target of $15. The firm cites the company’s Q3 earnings beat reported earlier this month while also boosting its FY25 EPS view by 3c to $2.15 and its FY26 view by 4c to $2.64, the analyst tells investors in a research note. Argus adds that thanks to its new products, Herbalife should see mid-single-digit revenue growth in 2025 following three consecutive years of declines. The firm also notes that at a 4.5-times earnings multiple, the stock “offers value”.